Notice of Intent to Publish a Funding Opportunity Announcement for Liver Cirrhosis Network: Clinical Research Centers (U01 Clinical Trial Required)
ID: 358910Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $330K

Eligible Applicants

Small Businesses

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/358910
Timeline
    Description

    The National Institutes of Health (NIH) intends to publish a Notice of Funding Opportunity (NOFO) for the Liver Cirrhosis Network: Clinical Research Centers (U01 Clinical Trial Required). This initiative aims to solicit applications for research focused on liver cirrhosis, specifically to complete enrollment in ongoing studies, including the Liver Cirrhosis Network Longitudinal Cohort Study and the RESCU clinical trial. The program is significant for advancing understanding and treatment of liver diseases, with an estimated total funding of $3,302,147 and an award ceiling of $330,214, anticipating approximately 10 awards. Interested applicants, particularly small businesses with expertise in liver disease research, are encouraged to prepare for application submission, with the estimated synopsis post date on July 11, 2025, and a closing date of August 15, 2025. For further inquiries, contact Edward Doo, MD, at dooe@niddk.nih.gov or call 301-451-4524.

    Point(s) of Contact
    Edward Doo, MD National Institute of Diabetes and Digestive and Kidney Diseases
    (301) 451-4524
    dooe@niddk.nih.gov
    Files
    No associated files provided.
    Similar Opportunities
    Notice of Intent to Publish a Funding Opportunity Announcement for Liver Cirrhosis Network: Scientific and Data Coordination Center (U24 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) intends to publish a Notice of Funding Opportunity (NOFO) for the Liver Cirrhosis Network: Scientific and Data Coordination Center, aimed at soliciting applications for research on liver cirrhosis. This initiative seeks to complete enrollment in two ongoing studies: the Liver Cirrhosis Network Longitudinal Cohort Study and the RESCU clinical trial, which evaluates the efficacy and safety of rosuvastatin for cirrhosis. The selected cooperative agreement will provide essential clinical studies management and biostatistical assistance for data analyses and dissemination of findings. Interested small businesses are encouraged to prepare for application submission, with an estimated total program funding of $1,835,051 and a projected award date of July 1, 2026. For further inquiries, potential applicants may contact Dr. Edward Doo at dooe@niddk.nih.gov or by phone at 301-451-4524.
    Interventions to Address Disparities in Liver Diseases and Liver Cancer (R01 - Clinical Trials Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Interventions to Address Disparities in Liver Diseases and Liver Cancer," aimed at supporting research interventions that target health disparities in liver diseases and liver cancer among marginalized populations in the United States. This initiative encourages researchers to propose multi-level and multi-domain approaches that address social determinants of health, with a focus on improving screening, treatment, and health outcomes for affected groups, including racial and ethnic minorities and individuals with lower socioeconomic status. The grant has no specific budget limit and allows for a maximum project period of five years, with applications accepted starting September 5, 2024. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries.
    Interventions to Address Disparities in Liver Diseases and Liver Cancer (R01 - Clinical Trials Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Interventions to Address Disparities in Liver Diseases and Liver Cancer," aimed at supporting research initiatives that develop and test multi-level and multi-domain interventions to reduce health disparities related to liver diseases among marginalized populations in the United States. The initiative encourages applicants to design community-engaged and culturally sensitive approaches focusing on screening, prevention, treatment, and management of liver conditions, particularly targeting racial and ethnic minorities, individuals of low socioeconomic status, and those in underserved communities. This grant is crucial for addressing systemic issues that influence health access and outcomes, with applications due starting January 5, 2025, and a maximum project duration of five years. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries.
    Notice of Intent to Publish a Notice of Funding Opportunity (NOFO) for the Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN)
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) for the Rare Diseases Clinical Research Consortia (RDCRC) as part of the Rare Diseases Clinical Research Network (RDCRN). This initiative aims to solicit applications for collaborative, multi-site research focused on advancing the diagnosis, management, and treatment of rare diseases, with an emphasis on addressing unmet clinical trial readiness needs. The funding, estimated at $1 million, will support specialized centers through cooperative agreements, with the NOFO expected to be published in winter 2024 and applications due in summer 2024. Interested applicants should prepare to develop meaningful collaborations, as the estimated award date is set for July 1, 2025.
    Notice of Intent to Publish a Funding Opportunity Announcement for Institutional Network Award for Promoting Kidney, Urologic, and Hematologic Research Training (U2C - Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) for the Institutional Network Award aimed at promoting research training in kidney, urologic, and hematologic fields. This initiative seeks to support institutions in developing a robust network to engage and train the next generation of researchers through innovative outreach and career development activities, with each institution eligible to apply for a single award to support at least five trainee slots. The total estimated funding for this program is $4 million, with an award ceiling of $2.1 million, and the NIH anticipates making approximately eight awards. Interested applicants can reach out to Dr. Tracy Rankin at rankint@niddk.nih.gov or (301) 594-4748 for further information, with the estimated synopsis post date set for July 5, 2025, and applications expected to be solicited by October 5, 2025.
    Notice of Intent to Publish the re-issuance of the Notice of Funding Opportunity (NOFO) Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN) (U54 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is set to re-issue the Notice of Funding Opportunity (NOFO) for the Rare Diseases Clinical Research Consortia (RDCRC) under the Rare Diseases Clinical Research Network (RDCRN), aimed at enhancing research in the diagnosis, management, and treatment of rare diseases. Each RDCRC is required to focus on at least three rare diseases and propose two to four clinical research projects, including one longitudinal study, emphasizing a collaborative, multi-site approach to address significant clinical trial readiness gaps. This initiative reflects the government's commitment to advancing public health through innovative methodologies and stakeholder engagement in the rare disease domain, with applications expected to be due in June and fall of 2025. Interested applicants can reach out to Dr. Tiina K. Urv at 301-827-2746 or via email at urvtiin@mail.nih.gov for further information.
    Forecast to Renew the Notice of Funding Opportunity Announcement for the Multiple Chronic Disease Research Centers
    National Institutes of Health
    The National Institutes of Health (NIH) is set to renew the Notice of Funding Opportunity (NOFO) for the Multiple Chronic Disease Research Centers, aimed at enhancing research on the prevention, diagnosis, treatment, and management of multiple chronic diseases (MCDs). This initiative will support both existing and new regional comprehensive research centers that focus on innovative strategies and interventions to improve health outcomes, particularly among populations facing health disparities. With an estimated total program funding of $55 million and the expectation of awarding 11 grants, potential applicants are encouraged to begin forming collaborations and developing projects, as applications are not currently being solicited. For further inquiries, interested parties may contact Dr. Dolly Penn at dolly.penn@nih.gov or by phone at 301-496-8676, with key deadlines including an estimated synopsis post date of May 16, 2025, and a close date of July 25, 2025.
    Forecast to Publish a Notice of Funding Opportunity (NOFO) for NCI Community Oncology Research Program (NCORP) Research Bases (UG1 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is set to publish a Notice of Funding Opportunity (NOFO) for the NCI Community Oncology Research Program (NCORP) Research Bases, which requires clinical trials. This initiative aims to enhance the generalizability and dissemination of clinical trial results by engaging cancer patient populations and organizations in rigorous studies focused on cancer control, prevention, treatment, and care delivery. The program will support seven awards with an estimated total funding of $60 million, and applications are open to small businesses. Interested applicants should note that the synopsis is expected to be posted on August 29, 2025, with a closing date for applications on November 14, 2025, and the anticipated award date is August 1, 2026. For further inquiries, contact Brandy Heckman-Stoddard, Ph.D., M.P.H., at 240-276-7048 or via email at heckmanbm@mail.nih.gov.
    Notice of Intent to Publish a Funding Opportunity Announcement for NCI National Clinical Trials Network - Network Group Integrated Translational Science Centers (UG1 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is forecasting a funding opportunity for the NCI National Clinical Trials Network - Network Group Integrated Translational Science Centers, designated as a UG1 Clinical Trial Not Allowed cooperative agreement. This initiative aims to support leadership and expertise in integrating translational science into clinical trials, particularly focusing on multi-center, late-phase treatment trials across various cancer types and patient demographics. The total estimated program funding is $2 million, with an award ceiling of $850,000 and an expected two awards to be made. The Notice of Funding Opportunity (NOFO) is anticipated to be published in Fall 2024, with applications due in late February 2025, and awards expected to be announced by March 1, 2026. Interested applicants should prepare their proposals accordingly.
    Notice of Intent to Publish a Funding Opportunity Announcement for Continuation of the NIDDK Hematology Central Coordinating Center (U24 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) plans to publish a Notice of Funding Opportunity (NOFO) for the continuation of the NIDDK Hematology Central Coordinating Center (HCC) under a cooperative agreement. The HCC will collaborate with up to five Cooperative Centers of Excellence in Hematology (CCEH) to provide administrative support, develop communication strategies, and implement educational programs aimed at enhancing research in nonmalignant hematology. This initiative is crucial for fostering a national multidisciplinary research effort to study hematopoiesis and address nonmalignant hematologic diseases. The estimated total program funding is $1 million, with a single award anticipated, and the NOFO is expected to be published in December 2024, with applications due by March 2025. For further details, potential applicants should prepare to submit their proposals in alignment with the requirements outlined in the forthcoming NOFO.